Alcohol and Cannabis Use Disorders

2022 ◽  
Vol 179 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Ned H. Kalin
Addiction ◽  
2013 ◽  
Vol 109 (2) ◽  
pp. 284-294 ◽  
Author(s):  
Carlos Blanco ◽  
Claudia Rafful ◽  
Melanie M. Wall ◽  
Ty A. Ridenour ◽  
Shuai Wang ◽  
...  

2018 ◽  
Vol 52 (03) ◽  
pp. 126-133 ◽  
Author(s):  
Patrik Roser ◽  
Eva-Maria Pichler ◽  
Benedikt Habermeyer ◽  
Wolfram Kawohl ◽  
Georg Juckel

Abstract Introduction Cannabis use disorders (CUD) are highly prevalent among patients with schizophrenia (SCZ). Deficient mismatch negativity (MMN) generation is a characteristic finding in SCZ patients and cannabis users. This study therefore examined the effects of CUD on MMN generation in SCZ patients. Methods Twenty SCZ − CUD patients, 21 SCZ+CUD patients, and 20 healthy controls (HC) were included in this study. MMN to frequency and duration deviants was elicited within an auditory oddball paradigm and recorded by 32 channel EEG. Results As expected, SCZ − CUD patients showed reduced frontocentral MMN amplitudes to duration deviants compared to HC. Interestingly, SCZ+CUD patients demonstrated greater MMN amplitudes to duration deviants compared to SCZ − CUD patients at central electrodes with no differences compared to HC. Discussion These results demonstrate that comorbid cannabis use in SCZ patients might be associated with superior cognitive functioning. It can be assumed that the association between cannabis use and better cognitive performance may be due to a subgroup of cognitively less impaired SCZ patients characterized by lower genetic vulnerability for psychosis.


2010 ◽  
Vol 120 (1-3) ◽  
pp. 101-107 ◽  
Author(s):  
Serge Sevy ◽  
Delbert G. Robinson ◽  
Barbara Napolitano ◽  
Raman C. Patel ◽  
Handan Gunduz-Bruce ◽  
...  

2022 ◽  
pp. 205-215
Author(s):  
Gabrielle E. Bowyer ◽  
Trevor M. Brooks ◽  
Deirdre A. Conroy

2019 ◽  
Vol 29 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Andrea H Weinberger ◽  
Lauren R Pacek ◽  
Melanie M Wall ◽  
Misato Gbedemah ◽  
Joun Lee ◽  
...  

BackgroundThe prevalence of cigarette smoking is nearly three times higher among persons who use cannabis and have cannabis use disorders (CUDs), relative to those who do not. The current study examined cigarette quit ratios from 2002 to 2016 among US adults with and without cannabis use and CUDs.MethodsThe current study analysed US adults aged 18 years and older from the National Survey on Drug Use and Health, an annual cross-sectional study. Quit ratios (ie, proportion of former smokers among ever-smokers) were calculated annually from 2002 to 2016. Time trends in quit ratios by cannabis use/CUDs were tested using logistic regression.ResultsIn 2016, the quit ratios for people with any cannabis use (23%) and CUDs (15%) were less than half the quit ratios of those without cannabis use and CUDs (51% and 48%, respectively). After controlling for demographics and substance use disorders, the quit ratio did not change from 2002 to 2016 among persons with CUD, though it non-linearly increased among persons with cannabis use, without cannabis use and without CUDs. Quit ratios increased more rapidly among those who reported past-month cannabis use compared with those without past-month cannabis use.ConclusionsCigarette smoking quit ratios remain dramatically lower among people who use cannabis and have CUDs and quit ratios did not change significantly from 2002 to 2016 among those with CUDs. Public health and clinical attention are needed to increase quit ratios and reduce harmful cigarette smoking consequences for persons with cannabis use and CUDs.


Sign in / Sign up

Export Citation Format

Share Document